YC, L., TY, C., HC, C., BH, L., M, M., YT, C., . . . CP, W. (2026). Attenuation of ABCG2-dependent drug efflux by befotertinib restores chemosensitivity in multidrug-resistant non-small cell lung cancer cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 200, 119613. https://doi.org/10.1016/j.biopha.2026.119613
Chicago Style (17th ed.) CitationYC, Li, et al. "Attenuation of ABCG2-dependent Drug Efflux by Befotertinib Restores Chemosensitivity in Multidrug-resistant Non-small Cell Lung Cancer Cells." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 200 (2026): 119613. https://doi.org/10.1016/j.biopha.2026.119613.
MLA (9th ed.) CitationYC, Li, et al. "Attenuation of ABCG2-dependent Drug Efflux by Befotertinib Restores Chemosensitivity in Multidrug-resistant Non-small Cell Lung Cancer Cells." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 200, 2026, p. 119613, https://doi.org/10.1016/j.biopha.2026.119613.